Atlas Trials

COVID-19 : Transcutaneous pO2 and pCO2 as Predictive Factors for Acute Respiratory Destress Syndrome in Patients Affected With SARS-Cov-2

Clinical trial NCT04524156 · UNKNOWN

Trial details

NCT number
NCT04524156
Sponsor
Erasme University Hospital
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
COVIDAcute Respiratory Distress SyndromeEndothelial Dysfunction
Start date
2020-10-04
Primary completion
2021-09-04
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.